RXSCI

RXSCI analyzes acute pharmacological management following spinal cord injury to quantify medication usage, timing, dosages, combinations, and reasons for administration during the acute to subacute phases.

Key Features:

• Data Integration: Integrates medication administration records from the Sygen interventional trial and the SCIRehab observational cohort study.
• Comprehensive Medication Tracking: Captures concomitant medication use with details on dosage, timing, and administration reasons, documenting polypharmacy up to 43 medications per day.
• Descriptive Statistical Analysis: Uses descriptive statistics to summarize counts, averages, and ranges of medications within the first 60 days post-injury and at 7, 14, 30, and 60 day intervals.
• Prophylactic Medication Identification: Identifies and quantifies medications administered prophylactically, comprising approximately 10% of acute administrations.

Scientific Applications:

• Understanding Polypharmacy Impacts: Evaluates how high degrees of polypharmacy may influence endogenous neurological recovery after spinal cord injury.
• Prophylactic Medication Analysis: Examines the prevalence and role of prophylactic medications in preventing complications such as pain or infections.
• Informing Clinical Practices: Identifies common pharmacological patterns and potential targets for optimizing medication regimens to support long-term recovery outcomes.

Methodology:

Systematically analyzes medication administration records from the Sygen and SCIRehab cohorts using descriptive statistical methods to summarize medication counts, averages, and ranges across specified post-injury time intervals (7, 14, 30, 60 days) within the first 60 days.